"After a meeting with Big Pharma executives in February, he backed down on his tough talk. This summer, this shameful retreat accelerated as evidenced by leaked White House documents detailing potential regulatory rollbacks sought by the industry but omitting any steps to lower drug prices. Why the turnaround? White House aide Joe Grogan, a former lobbyist for pharmaceutical giant Gilead, played a key role in this move, according to Kaiser Health News, which reported that the documents contained text "cribbed directly from policy papers" published by the main pharmaceutical industry lobbying group. Over at the Environmental Protection Agency, EPA administrator Scott Pruitt met with Dow Chemical's CEO just before deciding not to ban a Dow pesticide from being sprayed on food. Nancy Beck, a new official who formerly worked at a chemical industry lobbying group, played a key role in watering down the implementation of a crucial toxic chemicals rule, clashing with career experts in the process. And a coal industry lawyer appears likely to take the No. 2 job at EPA, beating out a coal industry lobbyist also considered for the job. These examples are representative rather than exceptional. Corporate America has captured the Trump administration. Public Citizen's research has found that more than 70% of Trump's picks for top sub-Cabinet jobs have clear corporate ties. In Trump's Washington, the populism of the campaign has been overtaken by conventional corporate cronyism on a grand scale. After his famous pledge to "drain the swamp," Trump issued a weak executive order allowing former lobbyists to immediately join the administration and then granted waivers to top White House staffers that render the ethics rules largely meaningless. For example, the White House concluded that it is "in the public interest" for Andrew Olmem, a White House aide who formerly lobbied MetLife, American Express and a major insurance trade group, to work on banking and insurance issues."